Abstract
Letter to editor in response to Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys.
Highlights
Robust assessments of chlamydia screening programme performance are urgently needed [1]
It is highly unlikely that serology will provide information at local level so analysis of routine surveillance data will still be required to monitor programme performance and address health inequalities, using methods such as our model, which estimates chlamydia incidence and prevalence by synthesising surveillance data with information on natural history and behavioural parameters [2, 4, 5]
Kounali et al speculate that ‘awareness campaigns linked to the National Chlamydia Screening Programme (NCSP) is likely to have increased diagnostic testing-seeking behaviour in asymptomatic women after a potential exposure’ [3], but provide no evidence
Summary
Robust assessments of chlamydia screening programme performance are urgently needed [1]. After more than a decade of screening by England’s National Chlamydia Screening Programme (NCSP), there is still not definitive evidence of effectiveness [2].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
